If you enjoyed reading this article from Tom Winnifrith
You can stop at any time.
This website will always remain free but if you enjoy its varied and controversial comment feel free to assist
with our running costs and to show your appreciation with a one off or regular donation. In advance, I thank you, Tom Winnifrith
Solvonis Therapeutics (SVNS) yesterday issued an RNS Reach Media Coverage: "Small Cap Idea profile in ThisIsMoney.co.uk / Daily Mail". What it says is not untrue or illegal but it is misleading and it's dirty.